These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 8729139
1. Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of various steps of growth signals. Terano T, Shiina T, Tamura Y. Lipids; 1996 Mar; 31 Suppl():S301-4. PubMed ID: 8729139 [Abstract] [Full Text] [Related]
2. Vascular smooth muscle cells preloaded with eicosapentaenoic acid and docosahexaenoic acid fail to respond to serotonin stimulation. Pakala R, Pakala R, Sheng WL, Benedict CR. Atherosclerosis; 2000 Nov; 153(1):47-57. PubMed ID: 11058699 [Abstract] [Full Text] [Related]
3. Eicosapentaenoic acid and docosahexaenoic acid suppress the proliferation of vascular smooth muscle cells. Shiina T, Terano T, Saito J, Tamura Y, Yoshida S. Atherosclerosis; 1993 Dec; 104(1-2):95-103. PubMed ID: 8141854 [Abstract] [Full Text] [Related]
4. Duality of n-3 Polyunsaturated Fatty Acids on Mcp-1 Expression in Vascular Smooth Muscle: A Potential Role of 4-Hydroxy Hexenal. Nagayama K, Morino K, Sekine O, Nakagawa F, Ishikado A, Iwasaki H, Okada T, Tawa M, Sato D, Imamura T, Nishio Y, Ugi S, Kashiwagi A, Okamura T, Maegawa H. Nutrients; 2015 Sep 21; 7(9):8112-26. PubMed ID: 26402697 [Abstract] [Full Text] [Related]
5. Eicosapentaenoic acid and docosahexaenoic acid inhibit vascular smooth muscle cell proliferation by inhibiting phosphorylation of Cdk2-cyclinE complex. Terano T, Tanaka T, Tamura Y, Kitagawa M, Higashi H, Saito Y, Hirai A. Biochem Biophys Res Commun; 1999 Jan 19; 254(2):502-6. PubMed ID: 9918868 [Abstract] [Full Text] [Related]
6. Epigallocatechin suppression of proliferation of vascular smooth muscle cells: correlation with c-jun and JNK. Lu LH, Lee SS, Huang HC. Br J Pharmacol; 1998 Jul 19; 124(6):1227-37. PubMed ID: 9720795 [Abstract] [Full Text] [Related]
8. Eicosapentaenoic acid inhibits vasopressin-activated Ca2+ influx and cell proliferation in rat aortic smooth muscle cell lines. Asano M, Nakajima T, Iwasawa K, Asakura Y, Morita T, Nakamura F, Tomaru T, Wang Y, Goto A, Toyo-oka T, Soma M, Suzuki S, Okuda Y. Eur J Pharmacol; 1999 Aug 27; 379(2-3):199-209. PubMed ID: 10497907 [Abstract] [Full Text] [Related]
9. Modulation of cyclin D1 and early growth response factor-1 gene expression in interleukin-1beta-treated rat smooth muscle cells by n-6 and n-3 polyunsaturated fatty acids. Bousserouel S, Raymondjean M, Brouillet A, Béréziat G, Andréani M. Eur J Biochem; 2004 Nov 27; 271(22):4462-73. PubMed ID: 15560787 [Abstract] [Full Text] [Related]
10. Eicosapentaenoic acid suppressed the proliferation of vascular smooth muscle cells through modulation of binding of growth factor. Terano T, Shiina T, Saito J, Tamura Y, Yoshida S. Jpn J Pharmacol; 1992 Nov 27; 58 Suppl 2():286P. PubMed ID: 1507556 [No Abstract] [Full Text] [Related]
12. n-3 polyunsaturated fatty acids stimulate osteoclastogenesis through PPARγ-mediated enhancement of c-Fos expression, and suppress osteoclastogenesis through PPARγ-dependent inhibition of NFkB activation. Nakanishi A, Tsukamoto I. J Nutr Biochem; 2015 Nov 27; 26(11):1317-27. PubMed ID: 26303404 [Abstract] [Full Text] [Related]
13. Mechanism of anti-proliferative action of eicosapentaenoic acid (EPA) in vascular cell growth: its effect on signal transduction system. Terano T, Hirai A, Shiina T, Tamura Y, Saitoh Y. Adv Exp Med Biol; 1997 Nov 27; 407():399-404. PubMed ID: 9321983 [No Abstract] [Full Text] [Related]
14. Docosahexaenoic acid potentiates interleukin-1beta induction of nitric oxide synthase through mechanism involving p44/42 MAPK activation in rat vascular smooth muscle cells. Hirafuji M, Machida T, Tsunoda M, Miyamoto A, Minami M. Br J Pharmacol; 2002 Jun 27; 136(4):613-9. PubMed ID: 12055140 [Abstract] [Full Text] [Related]
15. Mechanisms of enhanced production of PGI2 in cultured rat vascular smooth muscle cells enriched with eicosapentaenoic acid. Saito J, Terano T, Hirai A, Shiina T, Tamura Y, Saito Y. Atherosclerosis; 1997 Jun 27; 131(2):219-28. PubMed ID: 9199275 [Abstract] [Full Text] [Related]
16. Suppression by eicosapentaenoic acid of oxidized low-density lipoprotein and lysophosphatidylcholine-induced migration in cultured rat vascular smooth muscle cells. Kohno M, Yasunari K, Minami M, Kano H, Maeda K, Yoshikawa J. Metabolism; 2000 May 27; 49(5):560-2. PubMed ID: 10831162 [Abstract] [Full Text] [Related]
17. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells. Kim TJ, Yun YP. Vascul Pharmacol; 2007 Jan 27; 46(1):43-51. PubMed ID: 16875883 [Abstract] [Full Text] [Related]
18. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration. Pukac L, Huangpu J, Karnovsky MJ. Exp Cell Res; 1998 Aug 01; 242(2):548-60. PubMed ID: 9683541 [Abstract] [Full Text] [Related]
19. Eicosapentaenoic acid inhibits PDGF-induced mitogenesis and cyclin D1 expression via TGF-beta in mesangial cells. Hida M, Fujita H, Ishikura K, Omori S, Hoshiya M, Awazu M. J Cell Physiol; 2003 Aug 01; 196(2):293-300. PubMed ID: 12811822 [Abstract] [Full Text] [Related]
20. Influence of cellular incorporation of n-3 eicosapentaenoic acid on intracellular Ca2+ concentration and membrane potential in vascular smooth muscle cells. Asano M, Nakajima T, Hazama H, Iwasawa K, Tomaru T, Omata M, Soma M, Asakura Y, Mizutani M, Suzuki S, Yamashita K, Okuda Y. Atherosclerosis; 1998 May 01; 138(1):117-27. PubMed ID: 9678777 [Abstract] [Full Text] [Related] Page: [Next] [New Search]